Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.
about
Rifaximin for maintenance therapy in antibiotic-dependent pouchitisUlcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters CommitteeTreatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitisTreatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitisPouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitisUse of Biologics in Pouchitis: A Systematic ReviewProbiotics in inflammatory bowel diseases and associated conditionsCommon Inflammatory Disorders and Neoplasia of the Ileal Pouch: A Review of HistopathologyAn enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitisAssessment of mucosal inflammation and circulation in response to probiotics in patients operated with ileal pouch anal anastomosis for ulcerative colitis.Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance.Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.Prevalence and outcome of anemia after restorative proctocolectomy: a clinical literature review.Inflamed pouch mucosa possesses altered tight junctions indicating recurrence of inflammatory bowel disease.Medical therapy for induction and maintenance of remission in pouchitis: a systematic review.Detection of epithelial apoptosis in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposisPouchitis and pre-pouch ileitis developed after restorative proctocolectomy for ulcerative colitis: a case report.Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli.Do probiotics have a therapeutic role in gastroenterology?Pharmacotherapy for inducing and maintaining remission in pouchitis.Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis.Association between gastro-intestinal symptoms and menstruation in patients with ileal pouches.Family history of Crohn's disease is associated with an increased risk for Crohn's disease of the pouch.Pouchitis.Antineutrophil cytoplasmic antibodies in sera from colectomised ulcerative colitis patients and its relation to the presence of pouchitisMedical management of postoperative complications of inflammatory bowel disease: pouchitis and Crohn's disease recurrence.Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis.Short-term treatment with infliximab in chronic refractory pouchitis and ileitis.Review article: treatment of mild to moderate ulcerative colitis and pouchitis.Pouchitis in Children: Therapeutic Options.The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis.Characterization of the gut-associated microbiome in inflammatory pouch complications following ileal pouch-anal anastomosisThe prognosis of clinical course and the analysis of the frequency of the inflammation and dysplasia in the intestinal J-pouch at the patients after restorative proctocolectomy due to FAP.Differential expression of TLR2, TLR4 and JNK in mucosa of ileal pouches for ulcerative colitis. Is there a role for bacterial antigen pathway in asymptomatic patients?Local regulation of postprandial motor responses in ileal pouches.High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis.Impairment of epithelial transport but not of barrier function in idiopathic pouchitis after ulcerative colitis.Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitisHuman lymphocyte stimulation with pouchitis flora is greater than with flora from a healthy pouch but is suppressed by metronidazole.
P2860
Q21261868-5E5BD013-2BDC-4013-8F9B-6FA022C4F25CQ22242348-608CC954-D472-447D-BB33-2AE0E250626AQ24187707-E34716EB-8B96-45A5-BE57-24665E3F0AC1Q24234806-E3EB5925-CAC9-4C10-B5DA-B5630CBA7517Q24541353-CD364DCF-3BB1-4400-AB5B-EC83FA38E942Q26995117-6B35C048-8C2D-44BE-A7CF-02563EC8048EQ27002496-CFB711AF-F892-4702-AA09-AB525802B517Q28074139-209B19E3-A020-4C39-8FC1-8969C5CEF737Q28246860-2CDB35FC-AB94-4EFB-AB7A-38B96B952487Q30927782-3A821CE4-9C06-4CC0-A898-484086B5909CQ32026645-1243C420-B7E6-4254-881C-D39FA5B28E77Q33231186-453E4F30-B975-4276-B2A2-AD7448CBE0FAQ33436622-83F54885-7C91-45C5-B931-DF10CED512A7Q33458456-98F4B6B6-C8D4-450D-8C0E-F568A1FC29F8Q33535513-17D54F37-CE0F-4A74-8D2B-1625B282D234Q33745917-4E1A2618-9E35-4979-A8A9-5BD325AEC218Q33787979-06DFD574-FCB9-4D5B-B80F-D5EF39F82895Q33868113-E9E58C0D-8BCC-43B5-B872-0DE885323A50Q33869477-A9CB01C0-9D7A-457D-BCFE-66E3D675DE63Q33909095-91D050F4-AEBC-446E-87E7-89F1C57919CDQ34008761-43E905AD-ED14-46E7-A955-9ADC0C400242Q34012534-90393D4B-B3AA-46F6-948E-56E54555BD2FQ34019081-4A29F155-7DC5-4B84-AFCC-CA6851ACAEBBQ34233134-15F0B2F8-0931-4CA4-BD56-5F1CAC5CC4BDQ34409834-4333D971-626F-4351-8DFD-722E2A2405B1Q34429640-FB86BC9C-14EE-42D9-9C6B-002D9D3AE19CQ34504027-1B21D483-181A-4DED-B57E-A71BAE925E9FQ34533862-D8348AD6-573E-47DB-A3B4-D90EF3D4C603Q34588754-DC20B04C-5B84-441C-BA12-B181E94A0CF3Q34669202-B1CA73AF-719C-4957-A925-8172ABD718D6Q34808551-A99D84D4-7042-4B93-8679-23D3DD793966Q34955775-F90C1369-62A8-4C9F-A0B5-8586728C82A3Q35004592-123CAAFE-BB23-421D-AEC8-871284E6B8ADQ35172831-087FE755-C371-4E41-9F44-F182937F9B36Q35238764-F01BA2D2-4D7C-4A27-90B5-2C09A13E3947Q35357402-A794DD8F-8D73-4958-A902-29BCD84DED1DQ35365755-20D7DB51-D276-430A-8298-06D441305BFEQ35594644-E10B7E87-5F9F-469C-A1C1-3780E4CBE61EQ35596222-F3EC9066-2E13-46CA-AE14-A600CCDB310FQ35597016-DECDBD5C-0B02-4FE5-A2F8-39A76F9AEF06
P2860
Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.
@en
Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.
@nl
type
label
Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.
@en
Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.
@nl
prefLabel
Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.
@en
Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.
@nl
P2093
P1476
Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.
@en
P2093
J H Pemberton
S F Phillips
P304
P356
10.1016/S0025-6196(12)61634-6
P407
P577
1994-05-01T00:00:00Z